爱美客：10月28日召开董事会会议

Company Overview - Aimeike (SZ 300896) announced on October 28 that its 23rd meeting of the third board of directors will be held on October 28, 2025, combining on-site and remote voting methods [1] - For the year 2024, Aimeike's revenue composition is 99.9% from the medical device industry and 0.1% from other industries [1] - As of the report date, Aimeike's market capitalization is 49.5 billion yuan [1] Industry Context - The A-share market has surpassed 4,000 points, marking a significant resurgence after a decade of stagnation, with technology leading the market's transformation [1] - A new "slow bull" market pattern is emerging, indicating a potential shift in market dynamics [1]